CTRI/2023/02/049747招募中2 期
A Randomized parallel group active controlled trial to evaluate comparative efficacy of kutajadi vamaka yoga versus madanadi vamaka yoga in the management of Ekakushtha (Psoriasis)
Il0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.The patients who have given written informed consent.
- •2.Subjects fulfilling the eligibility criteria of Vamana (vamanarha).
- •3.Subjects with classical Lakshanas of Ekakushtha (Psoriasis) and clinical features of Psoriasis.
- •4.Subjects in moderate and severe category of psoriasis on basis of PASI scale (PASI score 5to 10, 10 and above).
- •5.Following types of Psoriasis were included: Plaque, Guttate, Palmoplantar
- •6.Subjects who have stopped medications for psoriasis for the last 90 days.
排除标准
- •1.Ekakushtha (Psoriasis) with extra cutaneous manifestations.
- •2.Subjects with uncontrolled metabolic disorders.
- •3.Patients with other systemic disorders which might interfere with the psoriasis treatment.
研究者
相似试验
已完成
2 期
EVALUATION OF CURCUMIN FOR THE TREATMENT OF DEEP CAVITIES IN MILK TEETH.CTRI/2013/11/004160Maratha Mandals NGH institute of Dental Sciences Research Centre Belgaum100
进行中（未招募）
不适用
A randomized, active controlled, parallel group, multi-center, two phase, open label study comparing safety and immunogenicity of Insugen R and Insugen N with Actrapid and Insulatard in patients with type 1 diabetes melllitus. - NADiabetes mellitus type 1MedDRA version: 12.1Level: LLTClassification code 10045228Term: Type I diabetes mellitusEUCTR2010-018354-12-HUBiocon S.A.286
尚未招募
2 期
Evaluating Efficacy of a Unani Formulation in HypertensioCTRI/2021/09/036158ational Research Institute of Unani Medicine for Skin Disorders
已完成
3 期
A clinical trial to study safety and efficacy of two drugs Insugen® R and Insugen® N with Actrapid® and Insulatard® in Patients with Type 1 Diabetes Mellitus.CTRI/2010/091/000627Biocon SA286
Unknown
3 期
A clinical trial to study safety and efficacy of two drugs Insugen® R and Insugen® N with Actrapid® and Insulatard® in Patients with Type 1 Diabetes Mellitus.CTRI/2009/091/000098Biocon S.A. Fid Borruat Sarl, Sous Maichereux 20 Case postale 2027 CH-2800, Delemont, Switzerland274